iShares LifePath Target Date 2040 ETF (NYSEARCA:ITDD – Get Free Report) shares fell 0.2% on Thursday . The company traded as low as $30.73 and last traded at $30.75. 15,657 shares changed hands during mid-day trading, an increase of 119% from the average session volume of 7,154 shares. The stock had previously closed at $30.80.
iShares LifePath Target Date 2040 ETF Stock Performance
The firm has a market capitalization of $27.39 million, a PE ratio of 20.96 and a beta of 0.81. The company’s 50-day moving average price is $31.13 and its 200-day moving average price is $31.17.
Institutional Inflows and Outflows
A hedge fund recently bought a new stake in iShares LifePath Target Date 2040 ETF stock. Heck Capital Advisors LLC purchased a new stake in iShares LifePath Target Date 2040 ETF (NYSEARCA:ITDD – Free Report) in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 1,310 shares of the company’s stock, valued at approximately $40,000. Heck Capital Advisors LLC owned approximately 0.47% of iShares LifePath Target Date 2040 ETF as of its most recent SEC filing.
iShares LifePath Target Date 2040 ETF Company Profile
The iShares LifePath Target Date 2040 ETF (ITDD) is an exchange-traded fund that mostly invests in target date asset allocation. The fund is an actively managed fund-of-funds that invests in equity, fixed income, and money market ETFs using an asset allocation strategy that shifts exposure as the target retirement date approaches.
Featured Articles
- Five stocks we like better than iShares LifePath Target Date 2040 ETF
- Learn Technical Analysis Skills to Master the Stock Market
- MarketBeat Week in Review – 03/24 – 03/28
- Conference Calls and Individual Investors
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- Why is the Ex-Dividend Date Significant to Investors?
- 4 Healthcare Stocks With Massive Gains—and More to Come
Receive News & Ratings for iShares LifePath Target Date 2040 ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares LifePath Target Date 2040 ETF and related companies with MarketBeat.com's FREE daily email newsletter.